# Apixaban (Eliquis)

Source: https://ourhealthnetwork.com/drugs/apixaban
Data: FDA Orange Book and OpenFDA, refreshed periodically

## What is Apixaban?

Apixaban (brand name: Eliquis) is a factor xa inhibitor. It is prescribed to treat venous thrombosis, pulmonary embolism. Across the United States, 246,000 doctors prescribe Apixaban to approximately 4.2 million Medicare patients, making it one of the 50 most prescribed drugs in America.

## Brand names

Eliquis

## Indications

Apixaban is prescribed for the treatment of venous thrombosis and pulmonary embolism.

## Conditions treated

- [Venous Thrombosis](https://ourhealthnetwork.com/conditions/venous-thrombosis)
- [Pulmonary Embolism](https://ourhealthnetwork.com/conditions/pulmonary-embolism)

## Mechanism of action

Apixaban is a selective inhibitor of FXa. It does not require antithrombin III for antithrombotic activity.

## Drug classification

- Established Pharmacologic Class: Factor Xa Inhibitor [EPC]
- Mechanism of Action class: Factor Xa Inhibitors [MoA]
- Route of administration: ORAL

## Common side effects

bleeding, bruising, nausea, anemia, nosebleed

## Sources and disclaimers

- FDA Orange Book and OpenFDA dataset
- This information is for educational purposes only and does not constitute medical advice. Always consult a healthcare professional before starting, stopping, or changing any medication.

## Related

- [All drugs](https://ourhealthnetwork.com/drugs)
- [Find specialists who prescribe this drug](https://ourhealthnetwork.com/find-doctors)
- [Methodology](https://ourhealthnetwork.com/methodology)